The Role of Platelet Rich Plasma for Erectile Dysfunction

Status Terminated

Clinical Trial Summary

Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.

Clinical Trial Description

Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25). Intervention and Evaluation:Men who consent to join the trial will be randomized to receive either a single injection PRP or saline to the penis. All patients will have blood drawn in clinic the day of injection. Those randomized to PRP arm will have their own blood prepared and separated into the PRP. This solution of their own blood will be injected back into the penis. Follow Up: Men will be evaluated at 1 , 3, and 6 months after the injections and then asked to complete the IIEF by phone or by electronic means ;

Study Design

Related Conditions & MeSH terms

Erectile Dysfunction

Clinical Trial Details

NCT number	NCT04357353
Study type	Interventional
Source	University of Nebraska
Contact
Status	Terminated
Phase	Phase 3
Start date	April 1, 2021
Completion date	November 2, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05366504` - LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment	Phase 2/Phase 3
Recruiting	`NCT02745808` - Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes	Phase 1
Recruiting	`NCT02573805` - the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males	N/A
Withdrawn	`NCT02579148` - Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes	Phase 1
Withdrawn	`NCT01967251` - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction	Phase 2
Recruiting	`NCT02225548` - Sagene 2014 - Parkinson's Disease and Erectile Dysfunction	Phase 4
Completed	`NCT02587988` - Trial to Evaluate the Efficacy and Safety of HCP1302	Phase 3
Completed	`NCT02945462` - Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)	Phase 1
Completed	`NCT01937871` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)	Phase 3
Completed	`NCT01698684` - Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction	Phase 4
Not yet recruiting	`NCT01321489` - A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies	Phase 3
Terminated	`NCT01262833` - Pudendal Assessment in Erectile Dysfunction	N/A
Completed	`NCT02226237` - Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy	N/A
Completed	`NCT01230541` - Effect of Udenafil on Spermatogenesis	Phase 1
Completed	`NCT01037244` - Treatment of Erectile Dysfunction I	Phase 3
Completed	`NCT01037218` - Treatment of Erectile Dysfunction II	Phase 3
Recruiting	`NCT00313898` - Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males	Phase 4
Completed	`NCT00421083` - Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury	Phase 3
Completed	`NCT00667979` - Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse	Phase 4
Completed	`NCT00663728` - Assessment of Duration of Erection With Vardenafil 10 mg	Phase 4